StockData
Profound Medical Corp. logo

Profound Medical Corp. (PROF) stock

PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$7.85+0.17 (+2.21%)

Close on Nov 11, 2026Market cap $286.78MP/E –Yield –

Profound Medical enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Profound Medical's enterprise value was $253.02M on Nov 11, 2026, against $178.93M a year earlier. Over the last 5 years it ranged from $15.52M to $253.02M, with a median of $154.17M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$253.02M+16.4%
2025Dec 31, 2025$217.28M+53.7%
2024Dec 31, 2024$141.38M+2.8%
2023Dec 29, 2023$137.50M-11.7%
2022Dec 30, 2022$155.70M+41.2%
2021Dec 31, 2021$110.31M-53.7%
2020Dec 31, 2020$238.03M+127.6%
2019Dec 31, 2019$104.59M–

More Profound Medical figures

See a number that looks wrong?